GALT vs PGR · $142.4M cap vs P/E 10, rev $45.80B
Galectin Therapeutics Inc (GALT) versus Progressive Corp (PGR) — a side-by-side from cached financials, not a winner call.
Galectin Therapeutics Inc (GALT) is a biotechnology company listed on US.
Progressive Corp (PGR) is a insurance - property & casualty company listed on NYSE.
GALT does not have a complete income-statement cache yet.
Latest reported PGR revenue for 2026-06-30 was $45.80B. Net income was $6.13B. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
GALT currently screens at market cap $142.4M. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
Not investment advice. Open the GALT and PGR stock pages for the full models.
Not investment advice.